Related Experiment Video
Updated: Mar 23, 2026
10:57
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
11.0K
Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy
Farzaneh Rami1, Halimeh Mollainezhad2, Mansoor Salehi1
1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Genetics Research International
|March 29, 2016
Summary
Cancer immunotherapy harnesses the immune system to fight tumors. Induced pluripotent stem cells (iPSCs) offer a promising new source for generating modified immune cells to enhance cancer treatment strategies.
Area of Science:
- Immunology
- Oncology
- Stem Cell Biology
Background:
- The immune system protects the host by distinguishing self from non-self, crucial for identifying and eliminating cancer cells.
- Cancer immunotherapy leverages the immune system's ability to target tumor cells, representing a novel therapeutic approach.
- Traditional methods for generating immune stimulatory cells face challenges in culturing and ex vivo manipulation.
Purpose of the Study:
- To review advancements in induced pluripotent stem cell (iPSC) technology for cancer immunotherapy applications.
- To highlight the potential of iPSCs as a source for modified immune cells in cancer treatment.
Main Methods:
- Review of recent progressions in iPSC technology.
- Exploration of iPSC-derived immune stimulatory cells for therapeutic use.
Main Results:
- iPSCs are emerging as a viable alternative source for generating modified immune cells.
- These cells can be engineered to enhance anti-tumor immune responses.
Conclusions:
- iPSC technology presents significant potential for advancing cancer immunotherapy.
- Further development in iPSC-based strategies could lead to more effective cancer treatments.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.2K
01:13Induced Pluripotent Stem Cells
28.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.5K
01:13Induced Pluripotent Stem Cells
4.0K
4.0K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K